Published in Int J Gen Med on October 05, 2012
Interaction of Depression and Nicotine Addiction on the Severity of Chronic Obstructive Pulmonary Disease: A Prospective Cohort Study. Iran J Public Health (2016) 0.77
COPD patients' medical care and support in Greece during financial crisis. Int J Gen Med (2016) 0.75
The pharmacological cost of COPD during Greek economic crisis. Int J Chron Obstruct Pulmon Dis (2017) 0.75
Do symptom-based questions help screen COPD among Chinese populations? Sci Rep (2016) 0.75
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med (2007) 47.86
Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet (1997) 44.03
Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med (1995) 33.41
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med (2007) 19.86
The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med (2004) 18.60
A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med (2008) 17.19
International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet (2007) 10.12
Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J (2008) 10.08
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax (2005) 7.39
Evaluation of clinical methods for rating dyspnea. Chest (1988) 4.12
Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J (2008) 4.11
Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J (2006) 3.89
Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest (2011) 3.72
Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax (2009) 3.54
Office spirometry significantly improves early detection of COPD in general practice: the DIDASCO Study. Chest (2004) 3.09
Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes. Thorax (2010) 3.06
Recent trends in physician diagnosed COPD in women and men in the UK. Thorax (2000) 3.02
Smokers with airway obstruction are more likely to quit smoking. Thorax (2006) 2.91
Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study. BMJ (2002) 2.35
Screening for and early detection of chronic obstructive pulmonary disease. Lancet (2009) 1.99
Lung function decline and outcomes in an adult population. Am J Respir Crit Care Med (2006) 1.98
Gender differences in survival following hospitalisation for COPD. Thorax (2010) 1.73
Prevalence of COPD in Greece. Chest (2004) 1.69
The 10-year COPD Programme in Finland: effects on quality of diagnosis, smoking, prevalence, hospital admissions and mortality. Prim Care Respir J (2011) 1.67
Scoring system and clinical application of COPD diagnostic questionnaires. Chest (2006) 1.66
Development and initial validation of a self-scored COPD Population Screener Questionnaire (COPD-PS). COPD (2008) 1.55
Cardiovascular risk in chronic obstructive pulmonary disease. Respirology (2007) 1.36
Extrapulmonary comorbidities in chronic obstructive pulmonary disease: state of the art. Expert Rev Respir Med (2011) 1.32
Predictors of mortality in COPD. Respir Med (2010) 1.23
Body composition by bioelectrical impedance predicts mortality in chronic obstructive pulmonary disease patients. Respir Med (2005) 1.17
Prevalence of chronic diseases and morbidity in primary health care in central Greece: an epidemiological study. BMC Health Serv Res (2010) 1.15
Co-morbidities of COPD in primary care: frequency, relation to COPD, and treatment consequences. Prim Care Respir J (2010) 1.10
Characteristics of adults dying with COPD. Chest (2002) 0.99
Comparison of a network of primary care physicians and an open spirometry programme for COPD diagnosis. Respir Med (2011) 0.83
Provide GPs with spirometry, not spirometers. Thorax (2008) 0.81
Foxp3 expression in human cancer cells. J Transl Med (2008) 1.94
Portable exhaled nitric oxide as a screening tool for asthma in young adults during pollen season. Chest (2007) 1.91
The association of metabolic syndrome with adipose tissue hormones and insulin resistance in patients with COPD without co-morbidities. COPD (2011) 1.61
Increased oxidative stress in exudative pleural effusions: a new marker for the differentiation between exudates and transudates? Chest (2005) 1.59
Haemodialysis patients with sleep apnoea syndrome experience increased central adiposity and altered muscular composition and functionality. Nephrol Dial Transplant (2007) 1.46
The role of leptin in the respiratory system: an overview. Respir Res (2010) 1.30
Clinical implications for vascular endothelial growth factor in the lung: friend or foe? Respir Res (2006) 1.22
Prevalence of chronic diseases and morbidity in primary health care in central Greece: an epidemiological study. BMC Health Serv Res (2010) 1.15
COPD prevalence and the differences between newly and previously diagnosed COPD patients in a spirometry program. Prim Care Respir J (2010) 1.10
Underdiagnosis of respiratory diseases during an economic downturn and the need for spirometry as a screening test. J Bras Pneumol (2013) 1.09
Indoleamine 2,3-dioxygenase (IDO) expression in lung cancer. Cancer Biol Ther (2007) 1.06
Helicobacter pylori infection and respiratory diseases: a review. World J Gastroenterol (2003) 1.06
Clinical, functional and biochemical changes during recovery from COPD exacerbations. Respir Med (2009) 1.03
Plasma leptin and adiponectin in COPD exacerbations: associations with inflammatory biomarkers. Respir Med (2009) 1.03
Circulating adhesion molecules levels in type 2 diabetes mellitus and hypertension. Int J Cardiol (2005) 1.03
Acute phase markers for the differentiation of infectious and malignant pleural effusions. Respir Med (2007) 1.01
VEGF, TNF-alpha and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer. Lung Cancer (2008) 0.99
Biomarkers in the exhaled breath condensate of healthy adults: mapping the path towards reference values. Curr Med Chem (2008) 0.98
Systemic and airway inflammation and the presence of emphysema in patients with COPD. Respir Med (2009) 0.97
Prevalence of sleep-related symptoms in a primary care population - their relation to asthma and COPD. Prim Care Respir J (2007) 0.96
Diabetes mellitus and lung function. Med Princ Pract (2003) 0.96
Depression and pulmonary function in outpatients with asthma. Respir Med (2004) 0.94
Nasal continuous positive airway pressure treatment reduces systemic oxidative stress in patients with severe obstructive sleep apnea syndrome. Sleep Med (2008) 0.94
Exhaled NO and exhaled breath condensate pH in the evaluation of asthma control. Respir Med (2010) 0.94
Global assessment of the COPD patient: time to look beyond FEV1? Respir Med (2009) 0.93
Matrix metalloproteinases in respiratory diseases: from pathogenesis to potential clinical implications. Curr Med Chem (2009) 0.92
Noninvasive ventilation in chronic respiratory failure: effects on quality of life. Respiration (2010) 0.92
Associations between BODE index and systemic inflammatory biomarkers in COPD. COPD (2011) 0.91
Statins and outcome after hospitalization for COPD exacerbation: a prospective study. Pulm Pharmacol Ther (2011) 0.89
Serum levels of oxidative stress as a marker of disease severity in idiopathic pulmonary fibrosis. Pulm Pharmacol Ther (2006) 0.88
Cytokine levels in the sera of patients with idiopathic pulmonary fibrosis. Respir Med (2005) 0.88
Co-expression patterns of tumor-associated antigen genes by non-small cell lung carcinomas: implications for immunotherapy. Cancer Biol Ther (2007) 0.88
Respiratory diseases and Helicobacter pylori infection: is there a link? Respiration (2006) 0.88
Vascular endothelial growth factor levels in pleural fluid and serum of patients with tuberculous pleural effusions. Chest (2005) 0.88
Prognostic value of C-reactive protein in parapneumonic effusions. Respirology (2012) 0.86
Vibration response imaging: evaluation of rater agreement in healthy subjects and subjects with pneumonia. BMC Med Imaging (2010) 0.86
Alterations of deadenylase expression in acute leukemias: evidence for poly(a)-specific ribonuclease as a potential biomarker. Acta Haematol (2012) 0.85
Clinical significance of serum adipokines levels in lung cancer. Med Oncol (2013) 0.85
Exhaled breath condensate pH as a biomarker of COPD severity in ex-smokers. Respir Res (2011) 0.85
Phenotypic mismatch repair hMSH2 and hMLH1 gene expression profiles in primary non-small cell lung carcinomas. Lung Cancer (2008) 0.84
Mitochondrial genetic background plays a role in increasing risk to asthma. Mol Biol Rep (2011) 0.84
Secondhand smoke exposure induces acutely airway acidification and oxidative stress. Respir Med (2012) 0.84
Chronic obstructive pulmonary disease exacerbation frequency and severity. Int J Chron Obstruct Pulmon Dis (2013) 0.84
Baseline levels of CD8+ T cells against survivin and survivin-2B in the blood of lung cancer patients and cancer-free individuals. Clin Immunol (2008) 0.84
Anti-survivin antibody responses in lung cancer. Cancer Lett (2009) 0.83
Comparison of a network of primary care physicians and an open spirometry programme for COPD diagnosis. Respir Med (2011) 0.83
Everyday clinical practice and its relationship to 2010 and 2011 GOLD guideline recommendations for the management of COPD. Prim Care Respir J (2013) 0.83
Pulmonary function and circulating adhesion molecules in patients with diabetes mellitus. Can Respir J (2003) 0.82
Naturally occurring tumor-specific CD8+ T-cell precursors in individuals with and without cancer. Immunol Cell Biol (2010) 0.82
Endothelial progenitor cells in the pathogenesis of idiopathic pulmonary fibrosis: an evolving concept. PLoS One (2013) 0.82
Serum VEGF levels are related to the presence of pulmonary arterial hypertension in systemic sclerosis. BMC Pulm Med (2009) 0.81
Anti-interleukin-5 therapy and severe asthma. N Engl J Med (2009) 0.81
ICAM-1, ICAM-2 and ICAM-3 in the sera of patients with idiopathic pulmonary fibrosis. Inflammation (2004) 0.81
Leptin, adiponectin, and ghrelin levels in female patients with asthma during stable and exacerbation periods. J Asthma (2012) 0.81
Hemoglobin, erythropoietin and systemic inflammation in exacerbations of chronic obstructive pulmonary disease. Eur J Intern Med (2010) 0.81
Differential expression of hypoxia-inducible factor 1α in non-small cell lung cancer and small cell lung cancer. Clinics (Sao Paulo) (2012) 0.81
Electromagnetic navigation diagnostic bronchoscopy and transbronchial biopsy. Chest (2008) 0.80
Prevalence of chronic obstructive pulmonary disease in Cyprus: a population-based study. COPD (2012) 0.80
Prisoners and cigarettes or 'imprisoned in cigarettes'? What helps prisoners quit smoking? BMC Public Health (2012) 0.80
Systemic oxidative stress in patients with pulmonary sarcoidosis. Pulm Pharmacol Ther (2009) 0.80
Interleukin-27 improves the ability of adenosine deaminase to rule out tuberculous pleural effusion regardless of pleural tuberculosis prevalence. Infect Dis (Lond) (2015) 0.80
Human parietal pleura present electrophysiology variations according to location in pleural cavity. Interact Cardiovasc Thorac Surg (2008) 0.80
Non-invasive ventilation in chronic hypercapnic COPD patients with exacerbation and a pH of 7.35 or higher. Eur J Intern Med (2007) 0.80
Phenotypes of comorbidity in OSAS patients: combining categorical principal component analysis with cluster analysis. J Sleep Res (2016) 0.80
Pleural electrophysiology variations according to location in pleural cavity. Interact Cardiovasc Thorac Surg (2009) 0.79
Pleural electrophysiology alterations in spontaneous pneumothorax patients. Interact Cardiovasc Thorac Surg (2010) 0.79
Diagnostic accuracy of biomarkers of oxidative stress in parapneumonic pleural effusions. Eur J Clin Invest (2010) 0.79
Body composition in severe refractory asthma: comparison with COPD patients and healthy smokers. PLoS One (2010) 0.79
Serum retinoic acid, retinol and retinyl palmitate levels in patients with lung cancer. Respirology (2006) 0.79
hMSH2 and hMLH1 gene expression patterns differ between lung adenocarcinoma and squamous cell carcinoma: correlation with patient survival and response to adjuvant chemotherapy treatment. Int J Biol Markers (2013) 0.78
Diabetes mellitus vs. Raynaud disease: different lung vascular bed disorders. Arch Med Res (2002) 0.78
Fetuin-A is associated with disease severity and exacerbation frequency in patients with COPD. COPD (2012) 0.78
Growth of thorax in genetic anemias: an index of deficit. Arch Med Res (2002) 0.78
Resting tension effect on airway smooth muscle: the involvement of epithelium. Respir Physiol Neurobiol (2005) 0.78
One-year non-invasive ventilation in chronic hypercapnic COPD: effect on quality of life. Respir Med (2008) 0.78
Residual pleural thickening is related to vascular endothelial growth factor levels in parapneumonic pleural effusions. Respiration (2009) 0.78
Environmetrics to evaluate marine environment quality. Environ Monit Assess (2007) 0.78
Azithromycin has a direct relaxant effect on precontracted airway smooth muscle. Eur J Pharmacol (2006) 0.77
Quantitative spectral analysis of vigilance EEG in patients with obstructive sleep apnoea syndrome: EEG mapping in OSAS patients. Sleep Breath (2010) 0.77
Matrix metalloproteinase levels in the differentiation of parapneumonic pleural effusions. Respiration (2010) 0.77
Heterozygous alterations of TNFRSF13B/TACI in tonsillar hypertrophy and sarcoidosis. Clin Dev Immunol (2013) 0.77
Polysomnographic evidence of sleep apnoea disorders in lean and overweight haemodialysis patients. J Ren Care (2008) 0.77
8-isoprostane levels in serum and bronchoalveolar lavage in idiopathic pulmonary fibrosis and sarcoidosis. Food Chem Toxicol (2013) 0.76
Increased primary autoimmune thyroid diseases and thyroid antibodies in sarcoidosis: evidence for an under-recognised extrathoracic involvement in sarcoidosis? Hormones (Athens) (2013) 0.76
Nonsteroidal anti-inflammatory drugs alter the human mesothelial pleural permeability via ion cellular transportation by inhibiting prostaglandin synthesis. Respiration (2012) 0.76
Association of bone mineral density, parameters of bone turnover, and body composition in patients with chronic obstructive pulmonary disease. J Clin Densitom (2011) 0.76
Concurrent sarcoidosis and melanoma: coexistence more than by chance? Dermatology (2010) 0.76
Yellow nail syndrome or diffuse lymphatic network disease. Acta Medica (Hradec Kralove) (2002) 0.75
The economic impact of late detection of COPD in general practice. Chest (2005) 0.75
Detection of COPD in high-risk populations. Chest (2002) 0.75
BMI and gastroesophageal reflux in women. N Engl J Med (2006) 0.75